11. Complement
in
the
pathogenesis
of
SLE
Sturfelt,
G.
&
Truedsson,
L.
(2012)
Complement
in
the
immunopathogenesis
of
rheumaKc
disease
Nat.
Rev.
Rheumatol.
doi:10.1038/nrrheum.2012.75
12. The
complement
pathway
most
involved
in
SLE
is:
• AlternaKve
Pathway
• Classical
Pathway
• Neoclassical
Pathway
• Straight
Pathway
14. Cytokines
in
SLE
• decreased
expression
of
interleukin
(IL)-‐2
• increased
produc;on
of
IL-‐17
and
related
cytokines
• B-‐cell
ac;va;ng
factor,
which
promotes
B-‐
cell
survival
and
autoan;body
produc;on
•
interferon-‐α,
which
acts
as
an
immune
adjuvant
• tumor
necrosis
factor,
which
contributes
to
organ
inflamma;on
Nature
Reviews
Rheumatology
6,
317-‐325
(June
2010)
15. Figure 1 Soluble BAFF and APRIL signalling
Vincent, F. B. et al. (2014) The BAFF/APRIL system in SLE pathogenesis
Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.33
16. Figure 3 Role of BAFF in the pathogenesis of SLE
Vincent, F. B. et al. (2014) The BAFF/APRIL system in SLE pathogenesis
Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.33
17. BAFF
is
a
member
of
which
cytokine
superfamily?
• Interferons
• IL-‐10
• TNF-‐Alpha
• Chemokines
18. Toll
–
Like
Receptors
:
Lead
to
IFN-‐Alpha
producKon
in
SLE
Liu
et
al
Nature
Medicine
2012
19. Interferon
in
SLE
IFN-‐α
produced
promotes
a.
DC1
development
b.
T
cell
acKvaKon
c.
autoanKbody
producKon
by
B
cells
20. The
Toll
Like
Receptors
primarily
involved
in
SLE
Pathogenesis
are
:
• 23,
6,
24
• 10,
11,
12
• 7,
8,
9
• 21,
17,
10